98%
921
2 minutes
20
Background: The risk of cancers associated with psychiatric disorders is understudied.
Aims: To investigate whether cancer risk varies with the presence of psychiatric disorders.
Method: Patients diagnosed with psychiatric disorders in South Korea between 1 January and 31 December 2017 were included in the study and referred to as the psychiatric disorder group. The non-psychiatric-disorder group, selected using a stratified random sampling technique based on age and gender, comprised individuals who had never been diagnosed with a psychiatric disorder. The primary outcome was a new cancer diagnosis, assessed over a 5-year period (1 January 2018 to 31 December 2022).
Results: Following 1:1 propensity score matching, the final analysis included data for 686 570 adults (343 285 in each group). The cancer incidence in the psychiatric disorder group from 2018 to 2022 was 15.4% (52 948/343 285), whereas in the non-psychiatric-disorder group, it was 12.8% (43 989/343 285). Cox regression analysis revealed that the psychiatric disorder group had a 23% higher occurrence of cancer compared with non-psychiatric-disorder controls (hazard ratio: 1.23, 95% CI: 1.21, 1.24; < 0.001). Significant associations between cancer incidence and specific psychiatric disorders were observed in individuals with alcohol-related disorders (hazard ratio: 1.27, 95% CI: 1.23, 1.32; < 0.001), anxiety disorders (hazard ratio: 1.15, 95% CI: 1.14, 1.17; < 0.001) and major depressive disorder (hazard ratio: 1.16, 95% CI: 1.15, 1.18; < 0.001).
Conclusions: Individuals with psychiatric disorders were more likely to develop cancer than those without. We identified associations of alcohol-related disorders, anxiety disorders and major depressive disorder with cancer risk.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188226 | PMC |
http://dx.doi.org/10.1192/bjo.2025.783 | DOI Listing |
J Surg Res
September 2025
Department of Surgery, Keck School of Medicine of USC, Los Angeles, California. Electronic address:
Introduction: Psychiatric comorbidities are increasingly recognized in patients with thoracic malignancies. We undertook this scoping review to characterize the management of thoracic malignancies in patients with psychiatric illness and uncover any disparities in operative treatment or perioperative outcomes.
Methods: We conducted a scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Comput Biol Chem
September 2025
Department of Physical Education, Xidian University, Xi'an 710126, China. Electronic address:
Parents of children with ASD face significantly greater parenting challenges than those raising typically developing children due to prolonged exposure to their children's developmental disorders, emotional distress, and atypical behaviors, underscoring the urgency of addressing their mental health concerns. This study examined the relationship between fear of negative evaluation (FNE) and social anxiety in parents of children with ASD, with a focus on the mediating roles of perceived social support and coping styles. A cross-sectional survey was conducted among 585 parents of children with ASD using validated instruments: the Brief Fear of Negative Evaluation Scale (BFNE), the Social Anxiety Scale, the Perceived Social Support Scale, and the Simple Coping Style Questionnaire.
View Article and Find Full Text PDFCell Rep
September 2025
Weill Cornell Medicine, New York, NY 10065, USA. Electronic address:
An adverse gestational environment is a risk factor for the development of psychiatric disorders. Although studies have implicated modifications in neuronal DNA and chromatin, how these changes come about and lead to abnormal behaviors is not known. We sought to identify persistent DNA/chromatin and transcriptomic signatures induced by a proinflammatory gestational environment in the ventral dentate gyrus (vDG), a hippocampal region linked to anxiety.
View Article and Find Full Text PDFAnn Med
December 2025
School of Acupuncture-Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: To review the biological functions of ergothioneine (ERGO), its correlation with plasma levels in cognitive frailty, and research progress in treating frailty and cognitive impairment, with the aim of providing a reference for ERGO application in cognitive frailty treatment.
Methods: A comprehensive review of existing literature on ERGO's chemical structure, sources, antioxidant and anti-inflammatory effects, and its role in cognitive frailty was conducted. Clinical trial data and metabolomic studies were also analyzed to understand ERGO's therapeutic potential.